The expressions of CD34 and cyclin D1 in AML cases with FLT3-ITD mutation were higher than in AML cases without this mutation (MFI 328.8 vs 25.78, p=0.003 and MFI 74.51 vs 57.15, P=0.005). This evidence concerns the gene FLT3 and acute myeloid leukemia.